Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FL.2.5ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
KK.1ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
KK.1ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
BA.2.3.17ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
BA.2.3.17ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
FG.2ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
FG.2ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
B.1.572ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
B.1.572ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
B.1.397ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
B.1.397ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
Q.3 (Alpha)ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
Q.3 (Alpha)ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
B.1.1.523ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
B.1.1.523ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
AY.116 (Delta)ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
AY.116 (Delta)ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
AY.38 (Delta)ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
AY.38 (Delta)ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
B.1.1.268ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
B.1.409ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
B.1.409ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
FG.1ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
FG.1ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
KV.1ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
KV.1ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
GK.1.6ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
GK.1.6ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
BA.5.2.31ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
BA.5.2.31ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
BA.5.1.9ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
BA.5.1.9ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
B.1.1.317ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
B.1.1.317ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
B.1.1.397ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
B.1.1.397ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
B.1.1.1ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
B.1.1.1ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
B.1.1.277ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
B.1.1.277ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
B.1.1.294ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
B.1.1.294ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
FR.1.1ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
FR.1.1ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
FU.2.1ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
FU.2.1ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
XBB.1.16.10ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
XBB.1.16.10ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
XBL.2ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
XBL.2ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used